Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Citigroup Inc. 

Prothena Corp. plc diskutieren

Prothena Corp. plc

WKN: A1KAVV / Symbol: PRTA / Name: Prothena Corp / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

21,60 €
1,94 %

Einschätzung Buy
Rendite (%) -49,45 %
Kursziel 67,71
Veränderung
Endet am 28.02.24

Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at Citigroup Inc. from $76.00 to $72.00. They now have a "buy" rating on the stock.
Ratings data for PRTA provided by MarketBeat

Einschätzung Buy
Rendite (%) -50,00 %
Kursziel 68,98
Veränderung
Endet am 03.04.24

Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat

Einschätzung Buy
Rendite (%) -69,52 %
Kursziel 114,81
Veränderung
Endet am 18.07.24

Prothena Co. plc (NASDAQ: PRTA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $129.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat

Einschätzung Buy
Rendite (%) -69,52 %
Kursziel 80,10
Veränderung
Endet am 18.07.24

Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat

Einschätzung Buy
Rendite (%) -45,73 %
Kursziel 121,34
Veränderung
Endet am 23.10.24

Prothena Co. plc (NASDAQ: PRTA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $129.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat

Einschätzung Buy
Rendite (%) -33,33 %
Kursziel 57,52
Veränderung
Endet am 12.12.24

Prothena Co. plc (NASDAQ: PRTA) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $62.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat

Einschätzung Buy
Rendite (%) -35,71 %
Kursziel 118,02
Veränderung
Endet am 18.12.24

Prothena Co. plc (NASDAQ: PRTA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $129.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat

Einschätzung Buy
Rendite (%) -35,71 %
Kursziel 79,47
Veränderung
Endet am 09.01.25

Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at Cantor Fitzgerald from $129.00 to $87.00. They now have an "overweight" rating on the stock.
Ratings data for PRTA provided by MarketBeat

Einschätzung Buy
Rendite (%) -25,00 %
Kursziel 73,90
Veränderung
Endet am 20.02.25

Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $98.00 to $80.00. They now have an "outperform" rating on the stock.
Ratings data for PRTA provided by MarketBeat

Einschätzung Buy
Rendite (%) -6,90 %
Kursziel 82,76
Veränderung
Endet am 18.03.25

Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat

Prothena Co. plc (NASDAQ: PRTA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for PRTA provided by MarketBeat

Einschätzung Buy
Rendite (%) 5,88 %
Kursziel 77,94
Veränderung
Endet am 09.05.25

Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at HC Wainwright from $90.00 to $84.00. They now have a "buy" rating on the stock.
Ratings data for PRTA provided by MarketBeat